首页> 外文期刊>国际眼科杂志:英文版 >Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
【24h】

Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma

机译:玻璃体腔内雷珠单抗联合全视网膜光凝加小梁切除术与艾哈迈德青光眼瓣膜植入术治疗新生血管性青光眼的疗效和安全性

获取原文
获取原文并翻译 | 示例
           

摘要

AIM:To evaluate the efficacy and safety of intravitreal ranibizumab(IVR)with panretinal photocoagulation(PRP)followed by trabeculectomy compared with Ahmed glaucoma valve(AGV)implantation in neovascular glaucoma(NVG).METHODS:This was a retrospective comparative study.We reviewed the cases of a total of 45 eyes from 45 NVG patients among which 23 eyes underwent AGV implantation and the other 22 underwent trabeculectomy. The causes of neovascular glaucoma included:diabetic retinopathy(25 eyes),and retinal vein occlusion(20 eyes).All patients received preoperative IVR combined with postoperative PRP. The mean best-corrected visual acuities(BCVA)were converted to the logarithms of the minimum angle of resolution(log MAR)for the statisitical analyses.Intraocular pressure(IOP),the log MAR BCVA and surgical complications were evaluated before and after surgery.The follow-up period was 12 mo.RESULTS:A total of 39 cases showed complete regression of iris neovascularization at 7d after injection,and 6 cases showed a small amount of residual iris neovascularization. The success rates were 81.8% and 82.6% at 12 mo after trabeculectomy and AGV implantation,respectively. In the trabeculectomy group,the log MAR BCVA improved at the last follow-up in 14 eyes,remained stable in 6 eyes and decreased in 2 eyes. In 4 cases,slight hyphemas developed after trabeculectomy. A shallow anterior chamber developed in 2 cases and 2 vitreous hemorrhages. In the AGV group,the log MAR BCVA improved in 14 eyes,remained stable in 5 eyes and decreased in 4 eyes. Slight hyphemas developed in 3 cases,and a shallow anterior chamber in 3 cases. The mean postoperative IOP was significantly lower in both groups after surgery(F=545.468,P<0.05),and the mean postoperative log MAR BCVA was also significantly improved(F=10.964,P<0.05)with no significant difference between two groups.CONCLUSION:It is safe and effective to treat NVG with this combined procedure,and we found similar results after IVR+AGV implantation+PRP and IVR+trabeculectomy+PRP in eyes with NVG.
机译:目的:评价玻璃体腔内雷珠单抗(IVR)联合小梁切除术联合全视网膜光凝术(PRP)与艾哈迈德青光眼瓣膜(AGV)植入治疗新生血管性青光眼(NVG)的有效性和安全性。方法:这是一项回顾性比较研究。 45例NVG患者共45眼,其中23眼行AGV植入,另外22眼行小梁切除术。新生血管性青光眼的病因包括:糖尿病性视网膜病变(25只眼)和视网膜静脉阻塞(20只眼)。所有患者均接受术前IVR联合术后PRP治疗。进行统计学分析,将最佳校正后的平均视力(BCVA)转换为最小分辨角(log MAR)的对数。评估术前和术后的眼压(IOP),log MAR BCVA和手术并发症。随访12个月。结果:注射后7d共39例虹膜新生血管完全消退,残余虹膜新生血管少量残留6例。小梁切除术和AGV植入术后12个月的成功率分别为81.8%和82.6%。小梁切除术组,末次随访时,MAR MAR BCVA log改善14眼,稳定6眼,下降2眼。 4例小梁切除术后出现轻度前房积血。浅前房形成2例,玻璃体出血2例。在AGV组中,log MAR BCVA改善了14只眼,稳定了5只眼,降低了4只眼。轻度前房积血3例,浅前房3例。两组术后平均眼压均明显降低(F = 545.468,P <0.05),平均术后log MAR MAR BCVA也明显提高(F = 10.964,P <0.05),两组之间无显着性差异。结论:该联合手术治疗NVG是安全有效的,我们在IVR + AGV植入+ PRP和IVR +小梁切除+ PRP治疗后发现了相似的结果。

著录项

  • 来源
    《国际眼科杂志:英文版》 |2017年第3期|P.400-405|共6页
  • 作者单位

    Qingdao University;

    Department of Ophthalmology,Qingdao Economic and Technological Development Area First People’s Hospital;

    Department of Ophthalmology,Laixi People’s Hospital;

    Department of Ophthalmology,Qingdao Traditional Chinese Medical Hospital of Huangdao District;

    Department of Ophthalmology,the Affiliated Hospital of Qingdao University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号